We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

EKF Diagnostics

Manufactures analysers for the measurement of glucose, lactate, hemoglobin, hematocrit and HbA1c for GP surgeries, ph... read more Featured Products: More products

Download Mobile App





EKF Diagnostics Presents Latest Diabetes Care Analyzers

By LabMedica International staff writers
Posted on 31 Jan 2019
EKF Diagnostics (Cardiff, Wales, UK) presented its latest diabetes care analyzers at MedLab Middle East, a leading laboratory and flagship exhibition and conference spanning across the Middle East, Asia and West Europe. More...
MedLab Middle East 2019 provided an international platform for laboratory management and medicine to exhibit their products ranging from ayurvedic & herbal to medical & pharmaceutical essentials in medical research & development & scientific instruments. The Conference provided education, best practices and the chance to learn, meet and network with leading laboratorians from across the globe.

At MedLab Middle East, EKF Diagnostics displayed DiaSpect Tm, the world’s fastest hemoglobin analyzer that delivers laboratory quality results in just about one second of the microcuvette being placed into the analyzer. The hemoglobin analyzer is palm-sized, making it easily transportable, and ideal for use in any screening setting even in challenging climatic environments. EKF Diagnostics also exhibited the Quo-Lab HbA1c desktop point-of-care analyzer for measuring glycated hemoglobin (HbA1c). The semi-automated analyzer has been designed specifically to meet the needs of diabetes clinics and laboratories in settings that demand low cost of operation and ease of use.

Also on display at the event was EKF Diagnostics’ Quo-Test HbA1c system, a fully automated HbA1c analyzer that uses patented boronate affinity fluorescence quenching technology to measure HbA1c from a 4-μl sample taken from a finger prick or venous whole blood. It has been designed for easy and reliable HbA1c measurement for the monitoring and management of diabetes in a point-of-care setting such as diabetes clinics and doctors’ surgeries. EKF Diagnostics’ also exhibited Hemo Control, its point-of-care hemoglobin analyzer designed to provide quantitative, lab quality hemoglobin results from 25 seconds. Hemo Control uses the most established photometric azide methemoglobin method, ensuring reliable results with a high precision (CV <2%).

Among the latest products displayed by EKF Diagnostics at MedLab Middle East was its new Lactate Scout 4 lactate analyzer for athletes. Lactate Scout 4 is used by sports medicine and sport professionals for the easy and reliable measurement of lactate while training on the track, working out in the gym or analyzing their performance in the laboratory. It has been ergonomically designed to be effectively used in the field as a training companion for coaches and athletes to determine optimum training programs, define training zones, and avoid inefficient training exercises. The hand-held lactate analyzer requires just 0.2 µl of capillary blood and returns results in 10 seconds. Up to 500 results can be stored on the Lactate Scout 4, which also features easy connection to heart rate monitors, stopwatch function to aid performance measurement, integrated step test function and Bluetooth connectivity.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
Drug Testing Assays
Atellica DT 250 Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.